Julie Young, B.Pharm, PhD
Vice President of Clinical Operations

Julie Young, B.Pharm, PhD has served as Vice President of Clinical Operations at Kinaset Therapeutics since August 2022. Prior to joining Kinaset, Julie served as an independent consultant providing expertise in clinical trial conduct, sponsor oversight and GCP compliance activities. Previously, she held a 12-year tenure at Vectura where she worked in Clinical Operations and managed planning and the conduct of clinical trials spanning from Phase I through Phase III for inhaled therapies through an outsourced model. At Vectura, Julie gained in depth experience in CRO engagement and the development of processes for trial conduct and sponsor oversight. Prior to Vectura, Julie led the Pharmaceutical Services group at Patheon (now Thermo Fisher), a CDMO. Before joining Patheon, Julie held project management roles of increasing responsibility in the UK and US for drug delivery technologies at Catalent. Early in her career, Julie served as a formulation scientist developing expertise on oral delivery systems after completing a degree in Pharmacy and earning her PhD in Pharmaceutical Sciences from the University of Nottingham.